Canada FR EN

Fresenius Kabi around the world

Africa & Middle East
- MENA
- South Africa
Asia Pacific
- Australia
- China
- China (Hong Kong SAR)
- India
- Indonesia
- Japan
- Korea
- Malaysia
- New Zealand
- Philippines
- Singapore
- Taiwan
- Thailand
- Vietnam
Europe
- Austria
- Belgium
- Croatia
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Great Britain
- Hungary
- Ireland
- Italy
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russian Federation
- Slovakia
- Spain
- Sweden
- Switzerland
Latin America
- Argentina
- Brazil
- Chile
- Colombia
- Ecuador
- Mexico
- Peru
North America
- Canada
- USA

Vinorelbine injectable, USP à 10 mg/mL en fioles de 5 mL Lancement de produit

juin 24, 2021